For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews
Health wasn’t the winner on the day
Wednesday 8 June 2022, 01:50 AM

Social determinants such as poverty and poor housing are driving up acute care demand [Image: Mihály Köles on Unsplash]
OPINION
The Government has come up with a health budget without a corresponding health strategy, writes Ian Powell
More than anything else, it is workforce that adds value to the accessibility and quality of patient care
In the lead-up to finance minister Gran
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.